Identification of a contact site for residue 19 of parathyroid hormone (PTH) and PTH-related protein analogs in transmembrane domain two of the type 1 PTH receptor

被引:41
作者
Gensure, RC
Shimizu, N
Tsang, J
Gardella, TJ
机构
[1] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Pediat Endocrine Unit, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA 02114 USA
关键词
D O I
10.1210/me.2003-0275
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Recent functional studies have suggested that position 19 in PTH interacts with the portion of the PTH-1 receptor (P1R) that contains the extracellular loops and seven transmembrance helices (TMs) (the J domain). We tested this hypothesis using the photoaffinity cross-linking approach. A PTHrP(1-36) analog and a conformationally constrained PTH(1-21) analog, each containing para-benzoyl-L-phenylalanine (Bpa) at position 19, each cross-linked efficiently to the P1R expressed in COS-7 cells, and digestive mapping analysis localized the cross-linked site to the interval (Leu232-Lys240) at the extracellular end of TM2. Point mutation analysis identified Ala234, Val235, and Lys240 as determinants of cross-linking efficiency, and the Lys240-->Ala mutation selectively impaired the binding of PTH(1-21) and PTH(1-19) analogs, relative to that of PTH(1-15) analogs. The findings support the hypothesis that residue 19 of the receptor-bound ligand contacts, or is close to, the P1R J domain - specifically, Lys240 at the extracellular end of TM2. The findings also support a molecular model in which the 1-21 region of PTH binds to the extracellular face of the P1R J domain as an alpha-helix.
引用
收藏
页码:2647 / 2658
页数:12
相关论文
共 65 条
[1]
Arginine 186 in the extracellular n-terminal region of the human parathyroid hormone 1 receptor is essential for contact with position 13 of the hormone [J].
Adams, AE ;
Bisello, A ;
Chorev, M ;
Rosenblatt, M ;
Suva, LJ .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (11) :1673-1683
[2]
Sauvagine cross-links to the second extracellular loop of the corticotropin-releasing factor type 1 receptor [J].
Assil-Kishawi, I ;
Abou-Samra, AB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (36) :32558-32561
[3]
STABILIZED NMR STRUCTURE OF THE HYPERCALCEMIA OF MALIGNANCY PEPTIDE PTHRP[ALA-26](1-34)AMIDE [J].
BARDEN, JA ;
KEMP, BE .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1994, 1208 (02) :256-262
[4]
NMR SOLUTION STRUCTURE OF HUMAN PARATHYROID HORMONE(1-34) [J].
BARDEN, JA ;
KEMP, BE .
BIOCHEMISTRY, 1993, 32 (28) :7126-7132
[5]
Photoaffinity cross-linking identifies differences in the interactions of an agonist and an antagonist with the parathyroid hormone/parathyroid hormone-related protein receptor [J].
Behar, V ;
Bisello, A ;
Bitan, G ;
Rosenblatt, M ;
Chorev, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (01) :9-17
[6]
Direct identification of two contact sites for parathyroid hormone (PTH) in the novel PTH-2 receptor using photoaffinity cross-linking [J].
Behar, V ;
Bisello, A ;
Rosenblatt, M ;
Chorev, M .
ENDOCRINOLOGY, 1999, 140 (09) :4251-4261
[7]
Full activation of chimeric receptors by hybrids between parathyroid hormone and calcitonin - Evidence for a common pattern of ligand-receptor interaction [J].
Bergwitz, C ;
Gardella, TJ ;
Flannery, MR ;
Potts, JT ;
Kronenberg, HM ;
Goldring, SR ;
Juppner, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (43) :26469-26472
[8]
Parathyroid hormone-receptor interactions identified directly by photocross-linking and molecular modeling studies [J].
Bisello, A ;
Adams, AE ;
Mierke, DF ;
Pellegrini, M ;
Rosenblatt, M ;
Suva, LJ ;
Chorev, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (35) :22498-22505
[9]
Nonlinear regression using spreadsheets [J].
Bowen, WP ;
Jerman, JC .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (12) :413-417
[10]
Studies of the N-terminal region of a parathyroid hormone-related peptide(1-36) analog:: Receptor subtype-selective agonists, antagonists, and photochemical cross-linking agents [J].
Carter, PH ;
Jüppner, H ;
Gardella, TJ .
ENDOCRINOLOGY, 1999, 140 (11) :4972-4981